Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy

Fig. 4

Unresponsive patients for PD-1 treatment had a significantly higher PMN-MDSC infiltration in TME when compared with responsive patients. A Tumor-infiltrating PMN-MDSC cell lineages (CD11b + CD15 + CD33 +) in PD-1-treated PCa samples; scale bar, 20 μm

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us